We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel Process Allows Manipulation of Parasite Surface Coating

By LabMedica International staff writers
Posted on 02 Jun 2009
Molecular microbiologists have used the protozoan parasite Leishmania major as a model system while developing a novel method for control of lipophosphoglycan (LPG) synthesis. More...
Lipophosphoglycan is a class of glycosyl phosphatidylinositol attached to a large polysaccharide structure that coats the surfaces of many parasitic protozoa. In Leishmania, this coat helps the parasite invade host cells while avoiding the host's immune response. It may also help in protecting against antimicrobial drugs.

In the May 5, 2009, issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS), investigators from the Washington University School of Medicine (St. Louis, MO, USAu) described a system for inducible expression of LPG, applying a novel protein-based system that allowed controlled degradation of a key LPG biosynthetic enzyme, UDP-galactopyranose mutase (UGM). This methodology relied on a mutated FK506-binding protein (FKBP) destabilizing domain (dd) fused to UGM. In the absence of rapamycin analogs, such as Shld1, the dd domain was destabilized, leading to proteasomal degradation of the enzyme, whereas drug treatment conferred stabilization. The concentration of rapamycin analog in the system determined to what extent UGM was degraded, which, in turn, determined how much LPG was synthesized.

"Leishmania's carbohydrate coat is important to the parasite's survival when it infects sand flies, the insects that transmit it, and in the early stages of human infections,” said senior author Dr. Stephen Beverley, professor of molecular microbiology at Washington University School of Medicine. "By manipulating the coat's presence, we hope to learn more about how it helps the parasite survive and potentially provide new targets for drug development. This opens up many new doors to studying Leishmania, because we have not previously had a way to manipulate the parasite in such a rapid and direct fashion. We are currently implanting this tuning system in several interesting proteins and using it to further study the carbohydrate coat.”

Related Links:
Washington University School of Medicine




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.